C21H21N7O3 — CID 172884252
N-[(4R,7S,8aS)-1-oxo-4-[(5-phenyl-1,3,4-oxadiazol-2-yl)methyl]-3,4,6,7,8,8a-hexahydro-2H-pyrrolo[1,2-a]pyrazin-7-yl]pyrazine-2-carboxamide (PubChem CID 172884252) has the molecular formula C21H21N7O3 and a molecular weight of 419.45 g/mol. Its IUPAC name is N-[(4R,7S,8aS)-1-oxo-4-[(5-phenyl-1,3,4-oxadiazol-2-yl)methyl]-3,4,6,7,8,8a-hexahydro-2H-pyrrolo[1,2-a]pyrazin-7-yl]pyrazine-2-carboxamide.
| Compound Name | N-[(4R,7S,8aS)-1-oxo-4-[(5-phenyl-1,3,4-oxadiazol-2-yl)methyl]-3,4,6,7,8,8a-hexahydro-2H-pyrrolo[1,2-a]pyrazin-7-yl]pyrazine-2-carboxamide |
|---|---|
| PubChem CID | 172884252 |
| Molecular Formula | C21H21N7O3 |
| Molecular Weight | 419.45 g/mol |
| Exact Mass | 419.17 |
| IUPAC Name | N-[(4R,7S,8aS)-1-oxo-4-[(5-phenyl-1,3,4-oxadiazol-2-yl)methyl]-3,4,6,7,8,8a-hexahydro-2H-pyrrolo[1,2-a]pyrazin-7-yl]pyrazine-2-carboxamide |
| SMILES | O=C(N[C@H]1C[C@H]2C(=O)NC[C@@H](Cc3nnc(-c4ccccc4)o3)N2C1)c1cnccn1 |
| InChI | InChI=1S/C21H21N7O3/c29-19(16-11-22-6-7-23-16)25-14-8-17-20(30)24-10-15(28(17)12-14)9-18-26-27-21(31-18)13-4-2-1-3-5-13/h1-7,11,14-15,17H,8-10,12H2,(H,24,30)(H,25,29)/t14-,15+,17-/m0/s1 |
| InChIKey | XHMMMOFFMVQYDC-UXLLHSPISA-N |
| XLogP | 0.44 |
| TPSA | 126.14 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 31 |
| Complexity | — |
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 419.45 |
| LogP ≤ 5 | 0.44 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |